Sentry Investment Management LLC Nektar Therapeutics Transaction History

Sentry Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$16.91 - $36.27 $157,533 - $337,891	-9,316 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$31.0 - $36.3 $2,325 - $2,722	-75 Reduced 0.8%	9,316 $331,000
Q1 2019 May 08, 2019	SELL	$31.58 - $46.35 $26,337 - $38,655	-834 Reduced 8.16%	9,391 $316,000
Q4 2018 Feb 11, 2019	SELL	$30.43 - $56.65 $8,155 - $15,182	-268 Reduced 2.55%	10,225 $336,000
Q2 2018 Aug 10, 2018	SELL	$46.25 - $104.45 $54,158 - $122,310	-1,171 Reduced 10.04%	10,493 $512,000
Q1 2018 May 02, 2018	BUY	$57.4 - $108.44 $669,513 - $1.26 Million	11,664 New	11,664 $1.24 Million

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $247M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Sentry Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Sentry Investment Management LLC with notifications on news.